Published in Mol Cancer on April 17, 2003
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell (2008) 4.06
The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities. Antioxid Redox Signal (2014) 2.26
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med (2009) 2.13
Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain. Proc Natl Acad Sci U S A (2009) 1.45
Histology-based expression profiling yields novel prognostic markers in human glioblastoma. J Neuropathol Exp Neurol (2005) 1.34
Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int J Cancer (2009) 1.12
The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells. BMC Cancer (2012) 1.09
Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer (2009) 1.07
Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release (2013) 1.05
Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma. BMC Cancer (2010) 1.05
ABC transporters in CSCs membranes as a novel target for treating tumor relapse. Front Pharmacol (2014) 0.98
Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells. Oncotarget (2015) 0.97
Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen. Gene Regul Syst Bio (2007) 0.97
SIRT of liver metastases: physiological and pathophysiological considerations. Eur J Nucl Med Mol Imaging (2012) 0.95
Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells. J Biol Chem (2012) 0.93
Transcriptional control of cancer metastasis. Trends Cell Biol (2013) 0.92
Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells. Sci Rep (2015) 0.88
HIF-1alpha modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines. J Cancer Res Clin Oncol (2009) 0.88
Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional cultures. Proteome Sci (2012) 0.88
Cancer stem cells and signaling pathways in radioresistance. Oncotarget (2016) 0.87
Homeobox gene Dlx-2 is implicated in metabolic stress-induced necrosis. Mol Cancer (2011) 0.87
SCO2 induces p53-mediated apoptosis by Thr845 phosphorylation of ASK-1 and dissociation of the ASK-1-Trx complex. Mol Cell Biol (2013) 0.86
Expression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319. J Exp Clin Cancer Res (2010) 0.85
Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro. World J Clin Oncol (2012) 0.81
Hypoxia Induces Autophagy through Translational Up-Regulation of Lysosomal Proteins in Human Colon Cancer Cells. PLoS One (2016) 0.80
Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel‑7402/5‑fluorouracil cells. Mol Med Rep (2014) 0.80
The effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model. Br J Cancer (2006) 0.79
Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines. Biomed Res Int (2013) 0.79
sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways. Oncotarget (2015) 0.79
PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment. J Mol Med (Berl) (2013) 0.78
Somatic mutations favorable to patient survival are predominant in ovarian carcinomas. PLoS One (2014) 0.78
The effect of antitumor glycosides on glioma cells and tissues as studied by proton HR-MAS NMR spectroscopy. PLoS One (2013) 0.78
Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment. Sci Rep (2016) 0.77
Emerging evidence of the physiological role of hypoxia in mammary development and lactation. J Anim Sci Biotechnol (2014) 0.77
Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors. Oncogenesis (2015) 0.77
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer (2017) 0.76
Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells. Front Oncol (2016) 0.76
Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer. Oncotarget (2016) 0.76
Effects of oxygen on the antigenic landscape of prostate cancer cells. BMC Res Notes (2015) 0.76
Genome maintenance and bioenergetics of the long-lived hypoxia-tolerant and cancer-resistant blind mole rat, Spalax: a cross-species analysis of brain transcriptome. Sci Rep (2016) 0.75
Evolutionary emergence of angiogenesis in avascular tumors using a spatial public goods game. PLoS One (2017) 0.75
Morning breathing exercises prolong lifespan by improving hyperventilation in people living with respiratory cancer. Medicine (Baltimore) (2017) 0.75
Role of compartmentalization on HiF-1α degradation dynamics during changing oxygen conditions: a computational approach. PLoS One (2014) 0.75
Modeling and analyzing gene co-expression in hepatocellular carcinoma using actor-semiotic networks and centrality signatures. Cancer Inform (2008) 0.75
Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme. J Transl Med (2015) 0.75
FBP1 expression is associated with basal-like breast carcinoma. Oncol Lett (2017) 0.75
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (1997) 29.34
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 24.57
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (2001) 22.06
ras oncogenes in human cancer: a review. Cancer Res (1989) 22.03
Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer (2002) 20.51
Mammalian MAP kinase signalling cascades. Nature (2001) 18.89
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (1992) 18.26
Signal transduction by the JNK group of MAP kinases. Cell (2000) 18.24
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet (1997) 15.38
Angiogenic factors. Science (1987) 15.22
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol (1996) 15.20
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (1995) 15.15
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta (1991) 11.78
Angiogenesis. J Biol Chem (1992) 11.29
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet (1997) 10.71
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (1996) 10.14
Genomic analysis of metastasis reveals an essential role for RhoC. Nature (2000) 10.11
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (1992) 10.10
Mitogen-activated protein kinase pathways. Curr Opin Cell Biol (1997) 9.10
Purification and characterization of hypoxia-inducible factor 1. J Biol Chem (1995) 8.53
Human chemokines: an update. Annu Rev Immunol (1997) 8.43
AP-1 function and regulation. Curr Opin Cell Biol (1997) 8.29
Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (1989) 8.10
Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (1992) 7.92
Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med (1995) 7.37
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev (2002) 7.08
The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A (1998) 6.98
Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med (1997) 6.86
FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev (2001) 6.35
Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res (2000) 6.14
Regulation of PTEN transcription by p53. Mol Cell (2001) 5.44
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep (2001) 5.32
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev (2000) 5.16
Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J (2002) 4.75
HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell (2001) 4.75
Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry (1985) 4.50
Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A (2000) 4.50
Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature (1997) 4.36
The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell (1994) 4.35
Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev (2000) 4.24
Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature (1998) 4.03
Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med (2000) 3.72
PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci (1997) 3.68
Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem (1990) 3.33
NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol (2001) 3.27
CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A (1998) 3.18
CXC chemokines in angiogenesis. J Leukoc Biol (2000) 3.17
PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res (1997) 3.15
Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol (2000) 3.12
Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell (1996) 3.00
Endothelial apoptosis in Braf-deficient mice. Nat Genet (1997) 2.77
Programmed cell death and Bcl-2 protection in very low oxygen. Nature (1995) 2.76
Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol (1990) 2.64
Halting angiogenesis suppresses carcinoma cell invasion. Nat Med (1997) 2.61
The ins and outs of Raf kinases. Trends Biochem Sci (1994) 2.51
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene (2000) 2.47
Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst (2001) 2.44
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (1995) 2.40
The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr Opin Cell Biol (2000) 2.38
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci (2002) 2.37
Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res (1996) 2.36
A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci U S A (1998) 2.34
Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res (1994) 2.28
Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol (2000) 2.22
Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol (1998) 2.11
MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev (1997) 2.09
Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res (1994) 2.02
Candidate genes for the hypoxic tumor phenotype. Cancer Res (2000) 1.94
Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc Natl Acad Sci U S A (1992) 1.82
Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene (1998) 1.81
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol (2000) 1.68
MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev (2000) 1.60
Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol (1998) 1.60
Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene (2001) 1.53
Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A (1995) 1.52
Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res (1999) 1.46
Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J (1997) 1.46
How oxygen makes its presence felt. Genes Dev (2002) 1.45
AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival. Oncogene (2002) 1.44
Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med (1997) 1.39
Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J Biol Chem (2001) 1.39
Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci U S A (1995) 1.39
Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol (1994) 1.39
A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc Natl Acad Sci U S A (1997) 1.38
Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res (2000) 1.37
Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene (2001) 1.34
Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene (1998) 1.29
Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure. J Biol Chem (2000) 1.24
Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res (1999) 1.23
Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res (1999) 1.23
Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol (1999) 1.16
The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol Cell Biol (2002) 1.12
The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B. Eur J Biochem (1995) 1.09
Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene (2000) 1.07
Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene (1999) 1.07
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol (2005) 3.42
Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res (2007) 2.62
Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat Immunol (2004) 1.44
Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol (2005) 1.20
Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm (2009) 1.17
Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering. Nat Commun (2013) 1.14
Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem (2003) 1.08
The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor. Mol Carcinog (2009) 1.03
Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73. Carcinogenesis (2007) 1.00
Dissecting the effects of mtDNA variations on complex traits using mouse conplastic strains. Genome Res (2008) 1.00
Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis. Am J Pathol (2006) 0.97
Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line. J Immunol (2006) 0.96
Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis. J Mol Med (Berl) (2005) 0.96
Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth. Clin Exp Metastasis (2010) 0.94
14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence. Mol Cancer (2009) 0.92
mtDNA nt13708A variant increases the risk of multiple sclerosis. PLoS One (2008) 0.90
The mtDNA nt7778 G/T polymorphism affects autoimmune diseases and reproductive performance in the mouse. Hum Mol Genet (2009) 0.90
Identification of new quantitative trait loci in mice with collagen-induced arthritis. Arthritis Rheum (2004) 0.90
Behavior and stress reactivity in mouse strains with mitochondrial DNA variations. Ann N Y Acad Sci (2009) 0.90
Proteome analysis of diseased joints from mice suffering from collagen-induced arthritis. Clin Chem Lab Med (2003) 0.90
Expressionview: visualization of quantitative trait loci and gene-expression data in Ensembl. Genome Biol (2003) 0.89
Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita. J Invest Dermatol (2012) 0.88
A proinflammatory role for Fas in joints of mice with collagen-induced arthritis. Arthritis Res Ther (2004) 0.88
Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease. Hum Mol Genet (2005) 0.87
Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. J Invest Dermatol (2010) 0.86
Gene-expression profiling of experimental autoimmune encephalomyelitis. Neurochem Res (2002) 0.86
Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris. J Invest Dermatol (2012) 0.86
Identification of quantitative trait loci for murine autoimmune pancreatitis. J Med Genet (2011) 0.86
High resolution mapping of Cia3: a common arthritis quantitative trait loci in different species. J Immunol (2009) 0.83
Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice. J Immunol (2011) 0.82
Combining global genome and transcriptome approaches to identify the candidate genes of small-effect quantitative trait loci in collagen-induced arthritis. Arthritis Res Ther (2007) 0.81
Non-major histocompatibility complex rheumatoid arthritis susceptibility genes. Crit Rev Immunol (2011) 0.81
Mutation of mitochondrial ATP8 gene improves hepatic energy status in a murine model of acute endotoxemic liver failure. Life Sci (2010) 0.80
Genetic control of psoriasis is relatively distinct from that of metabolic syndrome and coronary artery disease. Exp Dermatol (2013) 0.80
Chronicity of pristane-induced arthritis in rats is controlled by genes on chromosome 14. J Autoimmun (2003) 0.80
Definition of a 1.06-Mb region linked to neuroinflammation in humans, rats and mice. Genetics (2006) 0.80
Perforin deficiency attenuates collagen-induced arthritis. Arthritis Res Ther (2005) 0.79
Loss of imprinting of IGF2 characterises high IGF2 mRNA-expressing type of fibroblast-like synoviocytes in rheumatoid arthritis. Ann Rheum Dis (2009) 0.78
Genetic control of leucocyte--endothelial cell interaction in collagen-induced arthritis. Ann Rheum Dis (2010) 0.78
Collection of soluble variants of membrane proteins for transcriptomics and proteomics. In Silico Biol (2005) 0.78
Alterations in anxiety-like behavior following knockout of the uncoupling protein 2 (ucp2) gene in mice. Life Sci (2011) 0.78
Non-linear conversion between genetic and physical chromosomal distances. Bioinformatics (2004) 0.78
MS characterization of qualitative protein polymorphisms in the spinal cords of inbred mouse strains. Proteomics (2010) 0.78
Proteome analysis of brain in murine experimental autoimmune encephalomyelitis. Proteomics (2010) 0.77
Tumour necrosis factor receptor deficiency alters anxiety-like behavioural and neuroendocrine stress responses of mice. Cytokine (2012) 0.77
In silico fine-mapping: narrowing disease-associated loci by intergenomics. Bioinformatics (2004) 0.77
Genetic control of spontaneous arthritis in a four-way advanced intercross line. PLoS One (2013) 0.77
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE. J Autoimmun (2006) 0.76
Co-occurrence of autoantibodies in healthy blood donors. Exp Dermatol (2014) 0.75
Evidence of a role for Th17 cells in the breach of immune tolerance in arthritis. Arthritis Res Ther (2011) 0.75
Selecting SNPs for association studies based on population frequencies: a novel interactive tool and its application to polygenic diseases. In Silico Biol (2004) 0.75